WallStreetZenWallStreetZen

NASDAQ: WAY
Waystar Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WAY

Based on 12 analysts offering 12 month price targets for Waystar Holding Corp

Min Forecast
$30.00+8.48%
Avg Forecast
$33.92+22.64%
Max Forecast
$44.00+59.1%

Should I buy or sell WAY stock?

Based on 12 analysts offering ratings for Waystar Holding Corp.

Strong Buy
Strong Buy
8 analysts 66.67%
Buy
3 analysts 25%
Hold
1 analysts 8.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although WAY's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates WAY as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their WAY stock forecasts and price targets.

WAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-03
lockedlocked$00.00+00.00%2026-11-03
lockedlocked$00.00+00.00%2026-11-03
lockedlocked$00.00+00.00%2026-10-16
lockedlocked$00.00+00.00%2026-09-16
Barclays
Top 29%
72
HoldDowngrades$30.00+8.48%2026-09-15
RBC Capital
Top 28%
73
BuyReiterates$44.00+59.10%2026-08-27
Needham
Bottom 40%
40
BuyReiterates$33.00+19.33%2026-08-26
Truist Securities
Bottom 1%
1
Strong BuyMaintains$33.00+19.33%2026-08-13
UBS
Top 42%
59
Strong BuyMaintains$33.00+19.33%2026-07-30

1 of 2

Forecast return on equity

Is WAY forecast to generate an efficient return?

Company
11.41%
Industry
22.75%
Market
172.55%
WAY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is WAY forecast to generate an efficient return on assets?

Company
7.78%
Industry
17.25%
WAY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

WAY earnings per share forecast

What is WAY's earnings per share in the next 3 years based on estimates from 25 analysts?

Avg 1 year Forecast
$1.69+140.96%
Avg 2 year Forecast
$1.90+171.46%
Avg 3 year Forecast
$2.16+208.2%
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

WAY revenue forecast

What is WAY's revenue in the next 3 years based on estimates from 25 analysts?

Avg 1 year Forecast
$1.3B+2.79%
Avg 2 year Forecast
$1.4B+13.88%
Avg 3 year Forecast
$1.6B+27.35%
WAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WAY earnings growth forecast

How is WAY forecast to perform vs Health Information Services companies and vs the US market?

Company
45.25%
Industry
18.86%
Market
32.33%
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
WAY's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

WAY revenue growth forecast

How is WAY forecast to perform vs Health Information Services companies and vs the US market?

Company
8.21%
Industry
6.84%
Market
12.56%
WAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WAY vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
WAY$27.66$33.92+22.64%Strong Buy
MMED$18.85$25.42+34.84%Strong Buy
DOCS$32.60$26.65-18.26%Hold
HTFL$54.40$46.11-15.24%Strong Buy
PRVA$21.47$29.00+35.07%Buy
View Top Health Information Service Stocks

Waystar Holding Stock Forecast FAQ

Is Waystar Holding Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: WAY) stock is to Strong Buy WAY stock.

Out of 12 analysts, 8 (66.67%) are recommending WAY as a Strong Buy, 3 (25%) are recommending WAY as a Buy, 1 (8.33%) are recommending WAY as a Hold, 0 (0%) are recommending WAY as a Sell, and 0 (0%) are recommending WAY as a Strong Sell.

If you're new to stock investing, here's how to buy Waystar Holding stock.

What is WAY's earnings growth forecast for 2026-2028?

(NASDAQ: WAY) Waystar Holding's forecast annual earnings growth rate of 45.25% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 18.86%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.33%.

Waystar Holding's earnings in 2026 is $135,163,000.On average, 25 Wall Street analysts forecast WAY's earnings for 2026 to be $324,507,010, with the lowest WAY earnings forecast at $297,899,243, and the highest WAY earnings forecast at $355,539,784. On average, 25 Wall Street analysts forecast WAY's earnings for 2027 to be $365,582,629, with the lowest WAY earnings forecast at $326,180,817, and the highest WAY earnings forecast at $412,102,931.

In 2028, WAY is forecast to generate $415,065,763 in earnings, with the lowest earnings forecast at $375,202,211 and the highest earnings forecast at $456,545,404.

What is WAY's revenue growth forecast for 2026-2028?

(NASDAQ: WAY) Waystar Holding's forecast annual revenue growth rate of 8.21% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 6.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.56%.

Waystar Holding's revenue in 2026 is $1,262,710,000.On average, 25 Wall Street analysts forecast WAY's revenue for 2026 to be $249,724,372,084, with the lowest WAY revenue forecast at $239,142,830,894, and the highest WAY revenue forecast at $261,267,871,564. On average, 25 Wall Street analysts forecast WAY's revenue for 2027 to be $276,659,204,204, with the lowest WAY revenue forecast at $262,807,004,828, and the highest WAY revenue forecast at $310,712,527,670.

In 2028, WAY is forecast to generate $309,365,786,064 in revenue, with the lowest revenue forecast at $289,549,445,290 and the highest revenue forecast at $378,049,607,970.

What is WAY's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: WAY) forecast ROA is 7.78%, which is lower than the forecast US Health Information Services industry average of 17.25%.

What is WAY's Price Target?

According to 12 Wall Street analysts that have issued a 1 year WAY price target, the average WAY price target is $33.92, with the highest WAY stock price forecast at $44.00 and the lowest WAY stock price forecast at $30.00.

On average, Wall Street analysts predict that Waystar Holding's share price could reach $33.92 by Nov 3, 2027. The average Waystar Holding stock price prediction forecasts a potential upside of 22.64% from the current WAY share price of $27.66.

What is WAY's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: WAY) Waystar Holding's current Earnings Per Share (EPS) is $0.70. On average, analysts forecast that WAY's EPS will be $1.69 for 2026, with the lowest EPS forecast at $1.55, and the highest EPS forecast at $1.85. On average, analysts forecast that WAY's EPS will be $1.90 for 2027, with the lowest EPS forecast at $1.70, and the highest EPS forecast at $2.14. In 2028, WAY's EPS is forecast to hit $2.16 (min: $1.95, max: $2.37).

What is WAY's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: WAY) forecast ROE is 11.41%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.